ICON plc (ICLR)

117.34
NASDAQ : Health Technology
Prev Close 117.34
Day Low/High 0.00 / 0.00
52 Wk Low/High 76.81 / 124.65
Avg Volume 312.00K
Exchange NASDAQ
Shares Outstanding 54.08M
Market Cap 6.41B
EPS 5.20
P/E Ratio 23.10
Div & Yield N.A. (N.A)
ICON Announces Launch Of Government And Public Health Solutions To Support Global Public Health

ICON Announces Launch Of Government And Public Health Solutions To Support Global Public Health

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the rebranding of their acquired ClinicalRM...

ICON Reports Fourth Quarter And Full Year 2017 Results

ICON Reports Fourth Quarter And Full Year 2017 Results

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter...

ICON Issues Financial Guidance For Full Year 2018

ICON Issues Financial Guidance For Full Year 2018

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced its financial guidance for the year ended...

ICON Appoints Dr. James Cummings As President Of ClinicalRM

ICON Appoints Dr. James Cummings As President Of ClinicalRM

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr.

ICON Launches FIRECREST Pre-Screen To Improve The Speed And Accuracy Of Identifying Eligible Patients For Screening

ICON Launches FIRECREST Pre-Screen To Improve The Speed And Accuracy Of Identifying Eligible Patients For Screening

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of FIRECREST Pre-Screen, an innovative...

ICON Announces Appointment Of Ms. Joan Garahy To Board Of Directors

ICON Announces Appointment Of Ms. Joan Garahy To Board Of Directors

ICON plc , (NASDAQ: ICLR) global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Ms.

MediMedia Managed Markets, An ICON Company, Wins Two Gold Industry Awards For Data Analytics And Healthcare Communications

MediMedia Managed Markets, An ICON Company, Wins Two Gold Industry Awards For Data Analytics And Healthcare Communications

ICON plc, (NASDAQ: ICLR)) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that MediMedia Managed Markets, an ICON company,...

Medidata Selected By ICON To Evolve Image Management And Accelerate Research Goals For Sponsors And Sites During Clinical Trials

Medidata Selected By ICON To Evolve Image Management And Accelerate Research Goals For Sponsors And Sites During Clinical Trials

Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, and ICON (NASDAQ: ICLR), a global provider of drug development solutions and services to the...

ICON Contributes To Major European Research Study That Aims To Improve Treatment For Traumatic Brain Injury

ICON Contributes To Major European Research Study That Aims To Improve Treatment For Traumatic Brain Injury

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has contributed to a complex pan-European...

ICON Reveals Voice-Assistant Applications For Clinical Trials At ISPOR Annual European Congress

ICON Reveals Voice-Assistant Applications For Clinical Trials At ISPOR Annual European Congress

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today revealed proof-of-concept developments leveraging Voice...

ICON And The International Consortium For Health Outcomes Measurement Unveil The World's First Global Patient Outcomes Benchmarking Platform

ICON And The International Consortium For Health Outcomes Measurement Unveil The World's First Global Patient Outcomes Benchmarking Platform

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and the International Consortium for Health Outcomes Measurement...

ICON Reports Third Quarter 2017 Results

ICON Reports Third Quarter 2017 Results

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter...

ICON Announces Appointment Of Mr. Eugene McCague To Board Of Directors

ICON Announces Appointment Of Mr. Eugene McCague To Board Of Directors

ICON plc , (NASDAQ: ICLR) global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Mr.

ICON Acquires Mapi Group

ICON Acquires Mapi Group

ICON plc, (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has acquired the Mapi Group, a leading...

ICON Reports Second Quarter 2017 Results

ICON Reports Second Quarter 2017 Results

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter...

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions at the Annual General...

ICON Wins ELearning And Animation Awards For Its FIRECREST Digital Solutions

ICON Wins ELearning And Animation Awards For Its FIRECREST Digital Solutions

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that its FIRECREST solutions have won gold and...

ICON And DIA Amplify Thought Leadership And Debate With DIA Live 2017

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that for the second consecutive year it will present...

ICON Named By Forbes As One Of The Best Employers In America

ICON plc , (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been included in Forbes...

ICON Reports First Quarter 2017 Results

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter...

Parexel Is Discovering the Drugs of the Future

Parexel Is Discovering the Drugs of the Future

The midcap drug maker is finding growth as an outsourcing destination.

ICON Selected By The FDA To Validate Patient-Reported Outcome Endpoints For Antibacterial Drug Trials

ICON plc , (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded a project by the US...

ICON Reports Fourth Quarter And Full Year 2016 Results

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the fourth quarter...

ICON Issues Financial Guidance For Full Year 2017

ICON Issues Financial Guidance For Full Year 2017

ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced its financial guidance for the year ended...

ICON Further Enhances Clinical Trial Feasibility, Protocol Optimisation And Patient Recruitment Capabilities With TriNetX

ICON Further Enhances Clinical Trial Feasibility, Protocol Optimisation And Patient Recruitment Capabilities With TriNetX

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has further improved its feasibility,...

ICON Announces Appointment Of Mr. Ronan Murphy To Board Of Directors

ICON Announces Appointment Of Mr. Ronan Murphy To Board Of Directors

ICON plc , (NASDAQ:ICLR) global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Mr.

ICON Announces Executive Leadership Transition

ICON Announces Executive Leadership Transition

ICON plc , (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that, as part of its planned succession of...

ICON Reports Third Quarter 2016 Results

ICON Reports Third Quarter 2016 Results

ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter...

ICON Completes The Acquisition Of Clinical Research Management, Inc.

ICON Completes The Acquisition Of Clinical Research Management, Inc.

ICON plc , (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the previously announced...

Icon (ICLR) Marked As A Barbarian At The Gate

Icon (ICLR) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified Icon (ICLR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

TheStreet Quant Rating: A (Buy)